Who is sponsoring NCT00799682?

NCT00799682 is sponsored by Ophthalmic Consultants of Long Island.

What condition does NCT00799682 study?

NCT00799682 studies Dry Eye Disease.

What drugs are being tested in NCT00799682?

Interventions: Xalatan, Travatan Z.

What is the status of NCT00799682?

NCT00799682 is currently COMPLETED.

Last reviewed 2011-07-20 · How we verify

An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®

NCT00799682 Phase 4 COMPLETED

The purpose of this study is to determine if there is a difference in the ocular signs and symptoms of subjects' eyes using Xalatan® 0.005% versus Travatan Z® 0.004% based on the outcome of subject assessment and clinical assessment in patients with Ocular Hypertension or Glaucoma with mild to moderate dry eye at baseline in accordance with the Oxford Grading Scale.

Details

Lead sponsor	Ophthalmic Consultants of Long Island
Phase	Phase 4
Status	COMPLETED
Enrolment	56
Start date	2008-10
Completion	2011-02

Conditions

Dry Eye Disease

Interventions

Xalatan
Travatan Z

Primary outcomes

OSDI scores (patient's subjective assessment) — Eight Weeks

Countries

United States